{"disease":{"id":"mucopolysaccharidosis-type-i-mps-i","name":"mucopolysaccharidosis type i mps i"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05284006","title":"Non-invasive Functional Assessment and Pathogenesis of Morquio A","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Nemours Children's Clinic","has_results":false},{"nct_id":"NCT05073783","title":"A Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group With Pompe Disease or With Mucopolysaccharidosis Type I (MPS I) in a Home-care Setting","phase":"","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT03580083","title":"RGX-111 Gene Therapy in Patients With MPS I","phase":"PHASE1, PHASE2","overall_status":"SUSPENDED","enrollment_count":21,"lead_sponsor_name":"REGENXBIO Inc.","has_results":false},{"nct_id":"NCT01572636","title":"Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome","phase":"","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT04571970","title":"RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"REGENXBIO Inc.","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}